Search Results
Results found for "Nobel Prize"
- Dr. Hannes Schihada | Dr. GPCR Ecosystem
I spent 2 1/2 years in his lab and developed novel conformational sensors for these intriguing receptors
- Dr. Khaled Abdelrahman | Dr. GPCR Ecosystem
Molecular Medicine and Neuroscience at the University of Ottawa as a Postdoctoral Fellow to explore novel
- Dr. Nicola J. Smith | Dr. GPCR Ecosystem
Together with Irina Kufareva , UCSD, her team developed a novel approach to identifying ligands for orphan
- Dr. Andrew Tobin | Dr. GPCR Ecosystem
at the University of Glasgow, his primary research interests are focused on the rational design of novel
- Dr. Aylin Hanyaloglu | Dr. GPCR Ecosystem
at the University of California, San Francisco with Professor Mark von Zastrow where she identified novel
- Dr. Nicholas Holliday | Dr. GPCR Ecosystem
establishing a lab focused on G protein-coupled receptor kinetics, signaling, and trafficking and on using novel
- Dr. Tobi Langenhan | Dr. GPCR Ecosystem
cellular and organ functions, which require individual adhesion GPCRs, and extends to the development of novel
- Dr. Adriano Marchese | Dr. GPCR Ecosystem
The ultimate goal of Adriano’s research is to target novel aspects of GPCR signaling for therapeutic
- Dr. Katarina Nemec | Dr. GPCR Ecosystem
used for functional screens with state-of-the-art microscopy and high throughput screening to explain novel
- Kathryn Livingston: Allosteric Opioid Modulators and Receptor Signaling Beyond the Membrane | Dr. GPCR Ecosystem
Kathryn’s passion is developing solutions to problems in whatever form is most efficient: novel instrumentation , novel methods, or novel communication.
- Dr. Sudarshan Rajagopal | Dr. GPCR Ecosystem
His lab is also interested in identifying novel signal transduction mechanisms of GPCRs, such as the
- Dr. GPCR Board | Dr. GPCR Ecosystem
a scientifc idea to a thriving Biotech focusing on Systems Biology & AI to accelerate the quest for novel recognized expert on protease-activated receptors, particularly PAR1, and over the years she has discovered novel
- Anything BUT GPCRs with Dr. Mikel Garcia-Marcos | Dr. GPCR Ecosystem
systems (purified proteins, cultured cells, model organisms) in combination with the development of novel
- Signals, pH, and Discovery : Cracking GPCR Mysteries with Dr. Ian Chronis | Dr. GPCR Ecosystem
trafficking and signaling of adrenergic and proton-sensing receptors, with specific focus on identifying novel
- Dr. JoAnn Trejo | Dr. GPCR Ecosystem
recognized expert on protease-activated receptors, particularly PAR1, and over the years she has discovered novel
- Dr. Gregory Tall | Dr. GPCR Ecosystem
Tall moved upstairs to conduct his postdoctoral work on heterotrimeric G proteins and the novel interactor
- The Scientist's Compass: From Academia to Entrepreneurship with Dr. Dmitry Veprintsev | Dr. GPCR Ecosystem
Interdisciplinary Research & Future Directions – Exploring combinatorial drug actions, receptor interactions, and novel
- Self-Learning, Collaboration, and Delegation in Science with Dr. Badr Sokrat | Dr. GPCR Ecosystem
There, I completed a PhD in biochemistry exploring the non-canonical functions and possible novel mechanisms the impact of GPCR ubiquitination on signaling and β-arrestin functions, and the characterization of novel
- Aaron Sato: Synthetic Antibody Libraries for the Hardest GPCR Targets | Dr. GPCR Ecosystem
Aaron has a proven track record as a biologics leader as he led teams to discover and develop novel first-in-class technology to manufacture DNA at a scale, the team saw an opportunity to tackle the challenge of identifying novel
- Re-cap of Endocrine Metabolic GPCR 2024 with the Organizers | Dr. GPCR Ecosystem
at the University of California, San Francisco with Professor Mark von Zastrow where she identified novel
- How Lipid Rafts Organize GPCR Signaling | Dr. GPCR Ecosystem
efficacy and diagnostic innovation What the functional diversity of bitter taste receptors means for novel
- GPCR Assay Strategy, Bias, and Translational Drug Discovery | Dr. GPCR Ecosystem
the challenge of translating in vitro pharmacology to in vivo models, lessons on bias agonism, and novel
- Why Mosquitoes Hunt You: GPCR Control of Blood Feeding and Mating | Dr. GPCR Ecosystem
If you are considering novel ways to connect molecular pharmacology with organismal phenotype, especially
- Model. Predict. Discover. with Dr. Jens Carlsson | Dr. GPCR Ecosystem
believes modeling should predict , not just explain How his team uses structure-based modeling to identify novel
- Fluorescent Probes for GLP-1R and GIPR Imaging: From Cell Assays to In Vivo Systems | Dr. GPCR Ecosystem
His research group develops and applies novel technologies to investigate GLP-1 and GIP receptors — two
- David Gloriam: Orphan Receptors, GPCRDB, and the Data Revolution in GPCR Pharmacology | Dr. GPCR Ecosystem
structural pharmacology through the work of David Gloriam, whose career spans the identification of 26 novel his Ph.D. from Uppsala University in Sweden where he worked on the bioinformatic identification of 24 novel
- Dr. Alix A. J. Rouault | Dr. GPCR Ecosystem
Using this novel technique, I showed that MRAP2 biased GHSR1a signaling and shut down its constitutive
- Dr. GPCR Team | Dr. GPCR Ecosystem
Further down the track, he aims to apply this knowledge to develop novel chemical treatments for neuronal
- GPCR Retreat | Dr. GPCR Ecosystem
fellows, and principal investigators from academia and industry to discuss and debate existing and novel
- Tore Bengtsson: Rethinking β₂-Adrenergic Signaling in Metabolic Disease | Dr. GPCR Ecosystem
His work focuses on developing novel β₂-adrenergic ligands that selectively engage signaling pathways That’s what we’ve now achieved with new compounds that stimulate the receptor in a novel way.





























